$ Value
$0
Shares
478,800
Price
$0
Filed
Aug 29
Insider
Name
Zindrick Thomas
Title
President and CEO
CIK
0001937573
Roles
Transaction Details
Transaction Date
2025-08-27
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
478,800
Footnotes
Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter. | Includes 1514 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan. | The shares subject to the option will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Filing Info
Zindrick Thomas's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-24 | GNLX | ▼ | $9K |
| 2025-11-17 | GNLX | ▼ | $24K |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
Other Insiders at GNLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Yu Yong / Cappello Joseph
SVP, Clinical Development
|
— | $2K | 2026-03-24 |
|
Zindrick Thomas
President and CEO
|
— | $9K | 2026-03-24 |
| Thomas John | — | $29K | 2026-03-02 |
|
Smalling Ralph
Head of Regulatory
|
— | $1K | 2026-03-25 |